8-KOther EventsExhibits & Filings

Johnson Controls International plc 8-K Report, Corporate Update (Jul 5, 2005)

Filed July 5, 2005For Securities:JCI

Summary

This 8-K filing from Johnson Controls International plc (JCI), filed on July 5, 2005, primarily announces the company's acquisition of Vivant Medical. While the filing date is July 5, 2005, the event date is July 4, 2005, indicating the closing of the transaction. This acquisition is presented as a significant event for JCI, likely aimed at expanding its market presence or product portfolio within the medical sector. Investors should note that this report is a brief announcement of the acquisition and does not provide detailed financial terms or the strategic rationale behind the deal. Further information would typically be found in subsequent filings or investor presentations. The primary takeaway for investors is that JCI has completed a strategic acquisition, which could influence future growth and competitive positioning.

Key Highlights

  • 1Johnson Controls International plc (JCI) announced the acquisition of Vivant Medical on July 5, 2005.
  • 2The event date for the acquisition was July 4, 2005.
  • 3The acquisition was reported via a press release furnished as an exhibit to the 8-K.
  • 4This filing primarily serves to formally report the consummation of the acquisition.
  • 5The acquisition of Vivant Medical suggests a strategic move by JCI to expand its operations or market reach.

Frequently Asked Questions

The primary purpose of this 8-K filing was to officially report Johnson Controls' acquisition of Vivant Medical. The company issued a press release on July 5, 2005, announcing the completion of this acquisition.

The acquisition of Vivant Medical was completed on July 4, 2005, as indicated by the event date in the filing.

No, this 8-K filing is a brief announcement and does not provide specific financial details or the purchase price of the Vivant Medical acquisition. Such information might be found in subsequent filings or press releases.

The acquisition of Vivant Medical suggests that Johnson Controls was pursuing strategic growth by expanding its presence or capabilities, likely within the medical industry. This could indicate a move to broaden its product offerings or enter new market segments.